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a  b  s  t  r  a  c  t
Poly(ADP-ribose)  polymerase  1 (PARP-1)  plays  an important  role  in  DNA  repair,  but  also  contributes
to  other  aspects  of nucleic  acid  metabolism,  such  as  transcriptional  regulation.  Modiﬁcation  of  PARP-1
with  the small  ubiquitin-related  modiﬁer  (SUMO)  affects  its  function  as  a  transcriptional  co-activator
of  hypoxia-responsive  genes  and  promotes  induction  of  the  heat  shock-induced  HSP70.1  promoter.  We
now  report  that  PARP-1  sumoylation  is  strongly  inﬂuenced  by DNA.  Consistent  with  a  function  in tran-
scription,  we  show  that sumoylation  in  vitro  is enhanced  by binding  to intact,  but  not to  damaged  DNA,
in  a manner  clearly  distinct  from  the  mechanism  by  which  DNA  damage  stimulates  PARP-1’s  catalytic
activity.  An enhanced  afﬁnity  of  PARP-1  for  the  SUMO-conjugating  enzyme  Ubc9  upon  binding  to  DNAosttranslational modiﬁcation
NA  binding
NA repair
ranscription
is  likely  responsible  for  this  effect.  Sumoylation  does  not  interfere  with  the  catalytic  or  DNA-binding
properties of PARP-1,  and  structural  analysis  reveals  no  signiﬁcant  impact  of SUMO  on  the  conformation
of  PARP-1’s  DNA-binding  domain.  In  vivo, sumoylated  PARP-1  is  associated  with  chromatin,  but  the  mod-
iﬁcation  is  not  responsive  to DNA  damage  and  is not  affected  by  PARP-1  catalytic  activity.  Our  results
suggest  that  PARP-1’s  alternative  modes  of  DNA  recognition  serve  as  a means  to  differentiate  between
zyme
 201distinct  aspects  of  the  en
©
. Introduction
The biological properties of a protein can be altered by
ost-translational modiﬁcation with small chemical groups, such
s phosphate, or entire polypeptides, such as ubiquitin and
he small ubiquitin-related modiﬁer, SUMO [1]. In this way,
ost-translational modiﬁcation systems impinge on their targets
ithout the need for protein synthesis, and are consequently ableo mediate rapid responses to changes in the cellular environment.
ike other members of the ubiquitin family, SUMO controls a variety
f cellular pathways, ranging from nuclear import to transcriptional
egulation [2,3]. A prominent role in DNA metabolism is emerging
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from an involvement in several DNA repair systems [4]. In many
cases, SUMO modulates the interactions of its targets with other
cellular proteins by creating a binding site for a SUMO-binding
motif within the interaction partner [2,5]. However, SUMO con-
jugation can also alter the DNA-binding properties of its targets.
This is observed with the base excision repair factor Thymine DNA
Glycosylase (TDG), where sumoylation causes the release from an
abasic site within a stretch of double-stranded (ds)DNA [6–8], and
with the recombination factor Rad52, where sumoylation reduces
the afﬁnity for both single-stranded (ss) and dsDNA [9]. Conversely,
DNA binding can induce the modiﬁcation of a target protein. For
example, loading onto DNA strongly stimulates the sumoylation
of the budding yeast replication clamp, PCNA, in vivo and in vitro
[10], and similarly, ssDNA enhances the sumoylation of Rad52 in a
puriﬁed system [9]. Like ubiquitylation, SUMO conjugation is medi-
ated by a cascade of activating enzyme (E1), conjugating enzyme
(E2) and ligase (E3), with Ubc9 acting as the sole E2 and playing
a major role in substrate recognition by means of a direct bind-
ing motif, KX(D/E) (where  stands for a bulky aliphatic residue:
reviewed by [11]). Although many SUMO E3s harbour DNA-binding
domains that might explain a preferential sumoylation of DNA-
Open access under CC BY-NC-SA license.or chromatin-associated targets, the above-mentioned cases likely
involve changes in the properties or conformations of the target
proteins themselves, as the DNA-mediated stimulation of their
sumoylation does not require the presence of an E3 [9,10].
cense.
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Another post-translational modiﬁcation with an impact on DNA
etabolism is mediated by the family of poly(ADP-ribose) poly-
erases (PARPs) [12]. PARPs catalyse the transfer of ADP-ribose
oieties from NAD+ onto target proteins to form linear or branched
hains. PARP-1 is the most abundant member of the family and
t the same time the major acceptor of poly(ADP-ribose) in the
ell [13,14]. It is best known for its role as a damage sensor, as
ts binding to damaged DNA strongly stimulates its catalytic activ-
ty and thereby promotes the cellular response to DNA single- and
ouble-strand breaks (SSBs and DSBs) [15]. Recognition of unusual
NA structures, such as nicks and breaks but also loops and junc-
ions, is mediated mainly by an N-terminal DNA-binding domain
DBD) that contains two zinc ﬁnger motifs, F1 and F2 (Fig. 1A).
lthough F1 does not bind DNA very strongly, it is essential for
ctivation of PARP-1 by SSBs and DSBs [13,15–17]. In contrast,
2 has a high afﬁnity for DNA containing nicks or breaks, but is
ispensable for DSB recognition [16,18–21]. A third (structurally
nrelated) zinc-coordinating domain, F3, is also involved in the
timulation of PARP-1’s catalytic activity upon binding to damaged
NA [22–24]. A central automodiﬁcation domain (AD), encompass-
ng a BRCT domain for protein–protein interaction, is followed by
he C-terminal region containing a WGR  domain that collaborates
ith F1 and F3 in DNA binding and makes extensive interdomain
ontacts [20], and the catalytic fold (CAT).
In addition to its functions as a DNA damage sensor, PARP-
 plays a role in regulating gene transcription both under basal
onditions and in response to speciﬁc signals such as hormones,
ytokines, Ca2+ and heat shock [25]. Its contributions to transcrip-
ional regulation are mediated in several different ways: although
ARP-1 can act as a promoter-speciﬁc co-regulator and by bind-
ng to speciﬁc enhancer sequences and insulators, its predominant
unction in transcription can probably be attributed to a modu-
atory inﬂuence on chromatin structure. In fact, poly(ADP-ribose)
s recognised by speciﬁc chromatin-remodelling factors, but it can
lso directly affect chromatin compaction state [26–30]. Interest-
ngly, not all of PARP-1’s effects on transcription require its catalytic
ctivity [25,31].
PARP-1 has been identiﬁed as a SUMO target [32–35]. Mod-
ﬁcation of human PARP-1 by the SUMO isoforms SUMO-2 and
UMO-3 occurs predominantly at two sites, K203 and K486. These
odiﬁcations do not affect PARP-1’s catalytic activity, but appear
o impinge on its transcription-related functions [32,33]. Mess-
er et al. [32] demonstrated that PARP-1 sumoylation reduces
he expression of hypoxia-responsive genes in low-oxygen con-
itions, likely due to an inhibition of the interaction between
ARP-1 and the acetyl transferase CBP/p300. In contrast, Mar-
in et al. [33] showed that PARP-1 sumoylation contributes to
eat shock-induced activation of the HSP70.1 promoter. They also
ound that PARP-1 sumoylation was up-regulated following heat
hock, leading to its poly-ubiquitylation by the SUMO-targeted
biquitin ligase RNF4 and subsequent proteasomal degradation.
inally, Ryu et al. [34] reported an accumulation of SUMO-2/3-
odiﬁed PARP-1 on mitotic chromosomes in Xenopus laevis egg
xtracts and suggested a function for this modiﬁcation event in
ontrolling PARP-1’s activity towards other chromatin-associated
roteins.
In a search for chromatin-bound SUMO conjugates in X. lae-
is egg extracts, we independently identiﬁed PARP-1 as a target
f SUMO-2 (our unpublished data). In order to gain insight into
he nature of a putative cross-talk between the DNA-dependent
oly(ADP-ribosyl)ation and sumoylation systems, we have inves-
igated how DNA structure affects PARP-1 sumoylation. We
emonstrate here that sumoylation is strongly stimulated by intact
NA, but is not induced by DNA lesions. Our results lend support
o a DNA damage-independent function of PARP-1 sumoylation
nd suggest a mechanism for how the distinct functionalities of 12 (2013) 761– 773
the  polymerase could be delineated through its interactions with
relevant forms of DNA.
2.  Materials and methods
2.1.  Proteins and antibodies
Recombinant  PARP-1 F1 + F2 and PARP-1 F2 (WT  and R122I)
were produced and puriﬁed as described [18]. Full-length PARP-
1 (WT, K203R, K486R, K203/486R and C298A) was  produced
as an N-terminal His6-fusion in insect cells from pDEST10
derivative constructs and then puriﬁed by chromatography using 3-
aminobenzamide-sepharose 4B afﬁnity resin [36], HiTrap Heparin
and Superdex 200 (GE Healthcare). N-terminally His6-3C-tagged
SUMO-1 (WT  and T95R) was produced in bacteria from pET15
derivative vectors and isolated by Ni-NTA afﬁnity resin (Qia-
gen) and gel ﬁltration (Superdex 200). Untagged SUMO-1 was
generated in bacteria from pET11 derivative plasmids [37] and
puriﬁed by ultraﬁltration (MWCO  30,000, Vivaspin) and gel ﬁltra-
tion (Superdex 75). His6-tagged SUMO E1 was  puriﬁed according
to Yunus and Lima [38]. Untagged SUMO E1 was  purchased
from Boston Biochem. Untagged Ubc9 was puriﬁed as described
[37]. GSTUbc9 was  produced in Escherichia coli and puriﬁed
on glutathione Sepharose (GE Healthcare). Recombinant human
GSTRanGAP1 was from Novus Biologicals.
PARP-1 and the F1 + F2 fragment were detected by western
blot using mouse monoclonal antibody F1-23 (Enzo Life Sci-
ences). SUMO-1 and SUMO-2/3 were detected by polyclonal,
afﬁnity-puriﬁed antisera raised against His6-tagged recombinant
proteins. Antibodies against FLAG- and His6-tags were from Sigma,
those against GST, GAPDH, poly(ADP-ribose) and histone H3 from
Molecular Probes, AMS  Biotechnology, Trevigen and Millipore,
respectively.
2.2. Cell culture
All  cell lines were maintained in DMEM supplemented with
4.5 mg  mL−1 glucose, 2 mM glutamine, 15 g mL−1 phenol red
(11995-040, Invitrogen), 10% (v/v) heat-inactivated foetal bovine
serum, 100 U mL−1 penicillin and 100 g mL−1 streptomycin. For
detection of sumoylation sites in PARP-1, 60% conﬂuent HEK293
cells in 35 mm ∅  dishes were co-transfected with 1 g each of
pSG5-His6-SUMO-1 [39] and pDEST-PARP-1-FLAG3 (WT, K203R,
K486R, K233R, K249R, K512R, K203/486R, K233/486R, K249/486R,
K486/512R, K305/486R, K352/486R, or K442/486R) with 6 L of
Fugene HD (Roche). Cells were analysed 48 h post-transfection. For
detection of endogenous sumoylated PARP-1, HeLa cells carrying
a stably integrated tetracycline-inducible His6-SUMO-3 construct
[40] were grown in 150 mm ∅  dishes to 40% conﬂuency and incu-
bated in the presence or absence of 2 g mL−1 doxycycline for 24 h
before being exposed to the relevant conditions. For experiments
involving PARP-1 inhibition, cells were incubated with or without
10 M inhibitor (PJ34, Sigma) for 1 h before treatment with H2O2
(10 mM,  5 min) or camptothecin (1 M,  2 h). For cycloheximide
chase analysis, a tetracycline-inducible PARP-1 construct (WT  or
K203/486R) was stably integrated into HEK293 cells. After seeding
∼5 × 105 cells into 60 mm ∅  plates and growth for 24 h, cells were
induced with 1 mg  mL−1 doxycycline for another 24 h before wash-
ing and treatment with 50 g mL−1 cycloheximide in the absence
or presence of 30 M MG132.2.3. In vitro sumoylation assays
Sumoylation reactions were generally performed in 20 mM
HEPES-KOH pH 7.5, 110 mM KCH3CO2, 2 mM Mg(CH3COO)2, 0.05%
N. Zilio et al. / DNA Repair 12 (2013) 761– 773 763
Fig. 1. Sumoylation of PARP-1 F1 + F2 is stimulated by DNA. (A) Domain structure of PARP-1, indicating relevant domains and amino acids. F1–F3: Zn-coordinating domains;
AD: automodiﬁcation domain; CAT: catalytic domain. (B) In vitro sumoylation of F1 + F2 is strongly stimulated by DNA. Reactions were performed under standard conditions in
the  presence or absence of 150 ng supercoiled plasmid DNA. (C) Addition of heavily digested plasmid DNA (240 ng ≈ 360 pmol bp) stimulates sumoylation of F1 + F2 (3 pmol),
but  not the formation of free SUMO-1 chains. Western blots developed with anti-PARP-1 and anti-SUMO-1 antibodies show the respective conjugates. (D) Inﬂuence of SSBs
and  DSBs on the efﬁciency of F1 + F2 sumoylation. Enzymes: nicked – Nb.BsrDI (5 sites); 3′-overhangs – PstI (2 sites); 5′-overhangs – EcoRI (2 sites); blunt – EcoRV (2 sites).
(E) Inﬂuence of supercoiled versus relaxed DNA on the efﬁciency of F1 + F2 sumoylation. Relaxation was achieved by topoisomerase I treatment. (F) Inﬂuence of different
DNA sequences on the efﬁciency of F1 + F2 sumoylation. (G) Inﬂuence of DNA methylation on the efﬁciency of F1 + F2 sumoylation. The same plasmid was isolated from E. coli
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v/v) Tween 20, 0.2 g L−1 BSA and 1 mM DTT buffer contain-
ng: 25 nM SUMO E1 (His6-tagged unless otherwise stated), 150 nM
bc9, 300 nM SUMO (His6-tagged unless otherwise stated), 150 nM
f the relevant substrate and 2 mM ATP. The type and amount
f DNA included in the reactions are indicated in the relevant
gure legend. Analytical reactions were carried out in a total vol-
me of 20 L, 3 L of which were loaded onto either a 10% (w/v)
PARP-1 F1 + F2) or 6% (w/v) (full-length PARP-1) polyacrylamide
el. For mass spectrometry, the reaction was scaled up to 45 mL
or PARP-1 F1 + F2 (6.75 nmol together with 330 g supercoiled
lasmid DNA), and 1.3 mL  for the full-length protein (200 pmol
is6-PARP-1, untagged E1 and SUMO-1T95R and 15.6 g super-
oiled plasmid DNA). For NMR  analysis, the reaction was  scaled up
o 1.4 L (200 nmol 15N- and 13C-labelled PARP-1 F1 + F2 and 10 mg
upercoiled plasmid).2.4. In vitro interaction assays
DNA-binding assays were performed with 60 pmol of 15 bp
duplex DNA (biotinylated on one strand). Unlabelled DNA served as
a  negative control. The DNA was  incubated with 20 pmol of protein
(GSTUbc9 or F1 + F2) in 100 L of binding buffer (20 mM Tris–HCl,
pH 8.0, 125 mM NaCl, 1 mM MgCl2, 0.1% Triton, 1 mM DTT) on ice.
The mixture was  then added to 10 L of streptavidin agarose that
had been blocked with 5 mg  mL−1 BSA in binding buffer before, and
incubated with rotation at 4 ◦C for 1 h. The beads were washed three
times with 150 L of binding buffer, and bound material was  eluted
by boiling in SDS loading buffer. Binding of F1 + F2 to SUMO  was
examined in the same buffer as above, but containing 50 mM NaCl.
Proteins (20 pmol F1 + F2 or GSTUbc9 as control) were incubated
with 10 L of SUMO-2 agarose (Boston Biochem) in the presence
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r absence of 500 ng plasmid DNA with rotation at 4 ◦C for 1 h before
ashing three times with buffer and eluting bound material by boil-
ng in SDS loading buffer as above. Interactions between Ubc9 and
1 + F2 were assayed in the same way, using 60 pmol GSTUbc9 or GST
nd 20 pmol F1 + F2 orHisSUMO-1. Protein mixtures were incubated
n ice for 1 h and added to blocked glutathione Sepharose beads,
hich were then processed as before. Bound material was  analysed
y western blotting with relevant antibodies.
.5. Puriﬁcation of sumoylated proteins
Sumoylated PARP-1 (F1 + F2 and full-length) was puriﬁed from
eactions performed in the absence of BSA or Tween 20. Follow-
ng the addition of NaCl and imidazole to a ﬁnal concentration of
00 mM and 20 mM,  respectively, the reaction was  passed over a
isTrap HP column (GE Healthcare). For sumoylated PARP-1 F1 + F2,
he resin was washed in 50 mM Tris–HCl, pH 7.5, 200 mM NaCl,
 mM MgCl2, 20 mM imidazole, 1 mM DTT, exchanged to the same
uffer but containing 120 mM NaCl, incubated with GST-tagged
hinovirus 3C protease at a protease:SUMO molar ratio of 1:40
vernight at 4 ◦C, eluted through a GSTrap HP column to remove
he protease, and resolved by gel ﬁltration on a Superdex 75 column
quilibrated in 50 mM Tris–HCl, pH 7.5, 200 mM NaCl, 1 mM MgCl2,
 mM DTT. For sumoylated full-length PARP-1, the HisTrap HP resin
as washed with 20 mM HEPES-KOH, pH 7.5, 500 mM NaCl, 20 mM
midazole, 1 mM DTT, eluted with the same solution but containing
00 mM imidazole, dialysed into 100 mM NH4CH3COO and concen-
rated to 50 L by ultra-ﬁltration (MWCO  30,000).
.6.  Preparation of DNA ligands for sumoylation reactions
Sequences of the oligonucleotides used to assemble the vari-
us DNA ligands are given in Table S1. The dumbbell structure has
een described previously [18]. Plasmids were derivatives of pCR4-
lunt-TOPO (A, 4.8 kbp, Invitrogen), pET3 (B, 5.3 kbp, Merck) or
DEST32 (C, 5.5 kbp, Invitrogen). Histone octamers were assembled
n a 11 kbp long DNA molecule consisting of a tandemly repeated
87 bp long high-afﬁnity histone octamer binding sequence [41].
Digested and nicked plasmids (11 g) were prepared by incuba-
ion with 110 U of the relevant enzyme (New England Biolabs) for
 h at 37 ◦C (or 65 ◦C for nicking) in 120 L of the appropriate buffer.
elaxation of a supercoiled plasmid (5 g) was  brought about
y 5 U of topoisomerase I (Invitrogen) for 3 h at 37 ◦C in 500 L
f 50 mM Tris–HCl, pH 7.5, 50 mM KCl, 10 mM MgCl2, 0.1 mM
DTA, 30 mg  ml−1 BSA and 0.5 mM DTT. These DNA molecules were
leaned up with Qiagen’s QIAquick PCR Puriﬁcation Kit. Oligonu-
leotides (50 M in 50 mM Tris–HCl, pH 7.5, 250 mM  NaCl) were
nnealed by incubation at 98 ◦C or boiling water for 3 min  followed
y slow cooling to room temperature. The nicked dumbbell (20 M)
as sealed with 2000 U of T4 DNA ligase (New England Biolabs) for
6 h at 25 ◦C in total volume of 40 L. The reaction was terminated
y heating to 65 ◦C for 5 min.
.7. Mass spectrometry
Sumoylated PARP-1 (F1 + F2 and full-length) was subjected
o denaturation, reduction, alkylation and digestion by trypsin
Promega) in the Janus Liquid Handling System (PerkinElmer).
eptides were analysed on a SYNAPT HDMS mass spectrometer
Waters). The data were analysed against the UniProt database by
eans of the MASCOT algorithm (Matrix Science) using a precur-or tolerance of 5 ppm, a fragment ion mass tolerance of 0.8 Da,
ne missed trypsin cleavage site and variable modiﬁcations. MS/MS
ata were manually curated and validated using the Scaffold pro-
ramme  (Proteome Software). 12 (2013) 761– 773
2.8. NMR  spectroscopy
15N- and 13C-labelled sumoylated PARP-1 F1 + F2, sumoylated
with unlabelled SUMO-1, was analysed in 50 mM Tris–HCl, pH 7.0,
200 mM NaCl, 150 M ZnSO4, 4 mM [2H6] DTT and 5% (v/v) D2O
using a DMX600 spectrometer (Bruker) equipped with a triple
resonance (1H/15N/13C) cryoprobe. Data were acquired at 300 K
and 1H, 15N and 13C chemical shifts (ı) were calibrated using
sodium 3,3,3-trimethylsilylpropionate (Sigma) as an external 1H
reference. Spectra were analysed with either TOPSPIN (Bruker) or
SPARKY (Goddard, T.D. and Kneller, D.G., University of California,
San Francisco). Signals were assigned by analogy with the pre-
viously assigned F1 + F2 fragment [18]. Amide group chemical
shift perturbations between the unmodiﬁed PARP-1 F1 + F2 and
sumoylated PARP-1 F1 + F2 were calculated using the formula
ı =
√
((ı1H)2 + (ı15N/10)2).
2.9.  Detection of sumoylated PARP-1 in cultured cells
Unless otherwise noted, cells producing His6-SUMO (∼107)
were resuspended in 1 mL  of pulldown buffer (6 M guanidine
hydrochloride, 100 mM sodium phosphate, pH 8.0, 300 mM NaCl,
and 10 mM Tris–HCl, pH 8.0, 15 mM imidazole, 0.15% Tween 20)
containing 2 mM -mercaptoethanol, incubated at room temper-
ature for 1 h with rotation, sonicated for 20 s at 20% power on a
Branson Soniﬁer and supplemented with 20 L of Ni-NTA resin.
After an overnight incubation at room temperature, the resin was
washed three times in pulldown buffer containing 20 mM imidaz-
ole, and twice more in 8 M urea, 100 mM sodium phosphate, pH
8.0, 10 mM Tris–HCl and 30 mM imidazole, before bound material
was analysed by gel electrophoresis and western blot. For cell frac-
tionation, cells were lysed by resuspension in 10 mM HEPES, pH
7.9, 0.1% Triton X-100, 10 mM KCl, 1.5 mM MgCl2, 340 mM sucrose,
10% glycerol, 1 mM  PMSF, 5 g/mL aprotinin and 20 g/mL leu-
peptin, and incubation on ice for 10 min. Samples were centrifuged
at 1300 × g for 5 min, and the supernatant was used as the solu-
ble fraction. The pellet was resuspended in 20 mM Tris–HCl, pH
8.1, 2 mM EDTA, 500 mM NaCl, 0.1% SDS, 1% Triton X-100 with
CompleteTM protease inhibitor and incubated on ice for 10 min, fol-
lowed by sonication. After centrifugation at 16,100 × g for 5 min,
the supernatant was used as the chromatin fraction. For Ni-NTA
pulldown experiments, each fraction was combined with pulldown
buffer at a ratio of 1:1. Whole cell input samples were prepared in
NET-N lysis buffer (1% NP-40) by sonication.
2.10. PARP-1 activity assays
Catalytic  activity of PARP-1 was  determined using a colorimetric
assay kit with immobilised histones as substrate (Trevigen). Assays
were performed according to the manufacturer’s instructions, but
exchanging the supplied control DNA for double-stranded oligonu-
cleotides of varying lengths and amounts as indicated.
3.  Results
3.1. Sumoylation of the PARP-1 DNA-binding domain is affected
by  DNA
Detection of SUMO-modiﬁed PARP-1 predominantly in the
chromatin fraction ([33,34] and our unpublished results) prompted
us to examine the effect of DNA on PARP-1 sumoylation in vitro.
For these assays, we used SUMO-1 in order to minimise the extent
of poly-SUMO chain formation. In order to further reduce the
complexity of the experimental system, we used an N-terminal
fragment of PARP-1 that is liberated upon caspase cleavage in vivo
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aa 1–214) as a substrate for in vitro modiﬁcation assays. This frag-
ent, named F1 + F2, contains the two zinc ﬁnger motifs that have
een implicated in DNA binding and damage sensing and one of
he physiological sumoylation sites, K203 (Fig. 1A). In vitro sumoy-
ation of this protein by the E2 Ubc9 was strongly enhanced by the
ddition of DNA (Fig. 1B and C). In contrast, the formation of free
UMO chains or modiﬁcation of an unrelated substrate, RanGAP1,
nder the same conditions remained unaffected by DNA (Figs. 1C
nd S1), indicating that the stimulatory effect of DNA was  speciﬁc
or F1 + F2. Mass spectrometry conﬁrmed that K203 served as the
UMO acceptor site in vitro (Fig. S2).
Given that structural features of DNA such as nicks and breaks
trongly activate PARP-1’s catalytic activity, we  asked what types
f DNA structures would most effectively stimulate F1 + F2 sumoy-
ation. To our surprise, we observed that a circular supercoiled
lasmid enhanced the modiﬁcation efﬁciency to the same degree
s digested plasmid preparations containing blunt ends, 3′- or 5′-
verhangs (Figs. 1D and S3). A plasmid treated with a nicking
nzyme to introduce single-stranded breaks (SSBs) did not stim-
late the reaction. In contrast, relaxation of supercoiled plasmid
NA with topoisomerase I did not abolish its capacity to stimu-
ate F1 + F2 sumoylation (Figs. 1E and S3). This result indicates that
he observed difference between supercoiled and nicked DNA was
ue to the presence of SSBs rather than the absence of torsional
train or potential secondary structures such as loops or cruciforms
hat might result as a consequence of supercoiling. Stimulation
as comparable with three different plasmids of minimal sequence
dentity but similar size (Fig. 1F), indicating that the observed effect
as unlikely due to speciﬁc sequences. Finally, the presence or
bsence of the N6-adenine and C6-cytosine methylation patterns
ound in E. coli-derived DNA did not affect the ability of the DNA
o stimulate the reaction (Fig. 1G). Taken together, these results
ndicate that F1 + F2 sumoylation can be promoted in a sequence-
ndependent manner by various forms of DNA, including a relaxed
ircular plasmid without apparent secondary structural features.
ig. 2. Sumoylation of F1 + F2 is inhibited by SSBs. (A) Structure of the “nicked dumbbell”
ffect of supercoiled plasmid DNA (240 ng ≈ 360 pmol bp) on the sumoylation of F1 + F
nhibitory effects of DNA on sumoylation at K203. In vitro sumoylation was  performed as
D) Inactivation of F2 abolishes the effect of DNA on sumoylation. In vitro sumoylation of 12 (2013) 761– 773 765
However,  those structures that most effectively stimulate PARP-1’s
catalytic activity, i.e. SSBs, not only fail to activate sumoylation, but
apparently even inhibit the stimulatory effect of the accompanying
intact DNA.
3.2.  Binding to intact DNA, but not to strand breaks, promotes
PARP-1 F1 + F2 sumoylation
In order to explore this phenomenon further, we made use of
a structure representing a 5′-phosphorylated SSB ﬂanked by 9 bp
of double-stranded DNA and a hairpin on either side of the lesion,
thus avoiding the issue of double-stranded termini, to which PARP-
1 avidly binds (Fig. 2A). This nicked “dumbbell” accommodates the
footprint of PARP-1 on a SSB and is bound by F1 + F2 in a 1:1 stoi-
chiometry with high afﬁnity [18]. When titrated into an F1 + F2
sumoylation reaction in the presence of excess plasmid DNA, the
dumbbell at a 1:1 dumbbell:protein ratio signiﬁcantly inhibited the
stimulatory effect of the plasmid (Fig. 2B). Given that the F1 + F2
concentration in this experiment (150 nM) was only slightly above
the previously determined KD for this interaction [18], a moder-
ate excess of ligand would be expected to result in saturation, and
indeed we  observed full inhibition of sumoylation at a ratio of
2:1 (Fig. 2B). Since the second zinc ﬁnger motif (F2) exhibits the
highest afﬁnity for SSBs, we examined the effect of DNA on this
isolated domain (aa 103–214). As expected, both the enhancement
of sumoylation by plasmid DNA and its inhibition by addition of
the nicked dumbbell were comparable to the construct containing
both zinc ﬁnger motifs (Fig. 2C). Introduction of a point muta-
tion, R122I, that abolishes F2 DNA binding without affecting the
structural integrity of the domain [18] rendered the sumoylation
reaction insensitive to DNA (Fig. 2D). From these observations we
conclude that the F2 domain must recognise not only nicks, but
also intact DNA, and that of these only the latter promotes sumoy-
lation at K203. Competitive binding of the two forms of DNA, with
a strong preference for the nicked form, would then explain why
. (B) Addition of the nicked dumbbell (0.6, 1.5, 3 or 6 pmol) inhibits the stimulatory
2 (3 pmol). (C) The F2 domain (aa 103–214) is sufﬁcient for the stimulatory and
 in panel B, using 3 pmol F2, 240 ng plasmid DNA and 3 or 6 pmol nicked dumbbell.
WT and R122I mutant F2 domain was  performed as above.
766 N. Zilio et al. / DNA Repair 12 (2013) 761– 773
F of the
s  of 1H
L
s
p
3
P
a
v
a
g
a
f
a
n
e
t
F
t
o
u
eig. 3. Sumoylation does not change the properties of PARP-1 F1 + F2. (A) Outline 
tained gel showing the unmodiﬁed protein and the puriﬁed product. (B) Histogram
ocations of the F1 and F2 domains are indicated below the residue numbers.
toichiometric amounts of SSBs inhibit sumoylation even in the
resence of a large excess of binding sites on intact DNA.
.3.  Sumoylation does not affect the structure or DNA binding of
ARP-1 F1 + F2
Although sumoylation does not affect the DNA-dependent
ctivation  of poly-ADP ribose synthesis ([32,34] and our own  obser-
ations), the proximity of K203 to PARP-1’s DNA-binding domain
nd the impact of DNA on the sumoylation of this residue sug-
ested that the modiﬁcation might in turn inﬂuence the structure
nd/or DNA-binding properties of F1 + F2. We  therefore puriﬁed
ully sumoylated F1 + F2 to homogeneity (Fig. 3A). Consistent with
 previous report [32], the presence of SUMO on K203 did not sig-
iﬁcantly affect the afﬁnity of F1 + F2 for the nicked dumbbell by
lectrophoretic mobility shift assays (data not shown). In order
o directly examine the effect of SUMO on the structure of free
1 + F2, we modiﬁed an 15N- and 13C-labelled version of the pro-
ein with unlabelled SUMO-1 and compared the chemical shifts
f its backbone amide groups to those of the unmodiﬁed domain,
sing heteronuclear single quantum coherence (HSQC) NMR. As
xpected, the highest chemical shift perturbations were observed puriﬁcation procedure for sumoylated PARP-1 F1 + F2 and image of a Coomassie-
15N chemical shift perturbations in F1 + F2 upon modiﬁcation by SUMO-1 at K203.
at  and immediately around the SUMO attachment site. In addition,
some moderate perturbations were found at residues T109-F113,
which form a small loop at the extreme N-terminus of the ordered
region of F2 (Fig. 3B). It seems likely that these perturbations result
from minor changes in hydrogen bonding and ring current effects
(from F113), in turn probably reﬂecting a small change in the con-
formation of this loop caused by steric interaction with the SUMO
moiety. Thus, these data suggest that although SUMO might have
a slight preference in the way  it positions itself with respect to the
F2 domain in the conjugated form, it does not signiﬁcantly alter the
structure of F1 + F2 or make strong non-covalent contacts with any
of its residues.
3.4.  DNA affects the sumoylation of residues outside F1 + F2
In order to examine whether the striking effect of DNA on the
efﬁciency of PARP-1 sumoylation was  relevant in the context of
the full-length protein, we performed in vitro sumoylation reac-
tions with full-length PARP-1 in the absence and presence of a
supercoiled or relaxed plasmid. Addition of DNA resulted in the
formation of several high-molecular weight SUMO-1 conjugates
that suggested modiﬁcation of more than one residue (Figs. 4A and
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s  above.
4A). Mutation of each of the physiological acceptor sites, K203
nd K486, to arginine abolished distinct sets of conjugates, but a
eries of bands remained even in the K203/486R double mutant
Fig. 4B). Mass spectrometry analysis identiﬁed K486 and K512 as
ites of SUMO attachment in WT PARP-1 (Fig. S4B and C). K512
onforms to a sumoylation consensus motif (KXE), which may
xplain why it is targeted by Ubc9. These results demonstrate that
he ability of DNA to promote PARP-1 sumoylation is not limited to
he SUMO acceptor site immediately adjacent to PARP-1’s DBD, but
xtends to other sites within the protein, including the physiolog-
cally relevant K486. Hence, changes in the N-terminal F2 domain
pon binding to intact DNA must be transmitted to the rest of the
rotein.
.5. Residues outside F1 + F2 contribute to the effect of DNA on
ARP-1 sumoylation
As  expected from the results obtained with F1 + F2, the nicked
umbbell structure did not enhance the sumoylation of full-length
ARP-1, whereas an intact dsDNA dumbbell (Fig. S5) afforded a
obust stimulation of the reaction that was dependent on an intact
2 domain (Fig. 5A) and could be inhibited by competition with the
icked form (Fig. 5B).
In  order to characterise the requirements for stimulation of
ARP-1 sumoylation further, we examined the activities of blunt-
nded dsDNA oligonucleotides of different lengths in our in vitro
ssays (Fig. 5C). Stimulation of PARP-1 sumoylation was observed
ith dsDNA of a minimal length of 15 bp. This could reﬂect a binding
ither to the blunt ends or to the duplex itself, which corresponds
n size to the footprint of the F2 domain on a SSB (i.e. 7 bp on either
ide of the break) [21] and should therefore be able to accommo-
ate this domain. An 8 bp duplex did not stimulate sumoylation,
lthough it enhanced PARP-1’s catalytic activity as efﬁciently as
onger duplexes (Fig. S6), suggesting that a sufﬁcient stretch of
ntact dsDNA rather than free ends was required for the stimula-
ion. Duplexes longer than 15 bp were only slightly more efﬁcient,
hereas single-stranded oligonucleotides of comparable lengths
ere inactive. Very long ssDNA (61 nt) again provided an enhance-
ent of PARP-1 sumoylation, but this may  well be attributable to
egions of secondary structure within the sequence. In contrast
o dsDNA, a double-stranded RNA of 21 bp did not stimulate the
eaction at all (Fig. 5D), indicating that the effect was speciﬁc for
NA.
If the effect of DNA on PARP-1 sumoylation were entirely medi-
ted by the F2 domain, an inactivating mutation in this domain
n full-length PARP-1 should abolish all sensitivity of the reaction
o DNA, as observed before with the isolated F2 construct. We
herefore examined a mutant, R122/138A, which harbours a DNA
inding-deﬁcient F2 domain. Surprisingly, we found that whileof PARP-1 (3 pmol) is stimulated by the addition of supercoiled plasmid DNA
 blot. (B) In vitro sumoylation of WT PARP-1 and the indicated mutants, performed
short  duplexes had no effect on the mutant, a 61 bp dsDNA stimu-
lated the sumoylation of the mutant protein to the same extent
as that of wild-type PARP-1 (Fig. 5E and F). Similarly, plasmid
DNA at a non-saturating concentration was equally efﬁcient in
enhancing the sumoylation of the mutant and the wild-type protein
(Fig. 5G). Hence, long stretches of dsDNA appear to overcome the
need for F2, suggesting that DNA probably inﬂuences the sumoyla-
tion of full-length PARP-1 through regions other than the F2 domain
alone. Consistent with this notion, addition of the nicked dumb-
bell structure, which is speciﬁcally recognised by the F2 domain
[18], inhibited the stimulatory effect of a 15 bp, but not of a 61 bp
duplex (Fig. 5H). This difference was not due to the overall increased
amount of DNA in the latter case, as inhibition by the nicked dumb-
bell was not regained even when the molar amount of the 61 bp
duplex was  reduced fourfold (Fig. S7).
In order to address the question as to what parts of full-length
PARP-1 were involved in reacting to long stretches of dsDNA, we
introduced mutations into the F1 and F3 domains, as they had been
implicated in the DNA-dependent activation of PARP-1. Although
we were unable to obtain an F1 mutant that did not heavily aggre-
gate in vitro (data not shown), the F1 motif is unlikely to mediate the
length-dependent phenomenon, because in the context of PARP-1
F1 + F2, the nicked dumbbell was capable of inhibiting the stim-
ulation of sumoylation induced by long plasmid DNA  (Fig. 2C).
Inactivation of F3 by a C298A mutation yielded soluble protein,
but to our surprise the mutant behaved very similar to wild-type
PARP-1 with respect to the length dependence of stimulation and
inhibition of the sumoylation reaction (Fig. S8). If anything, sumoy-
lation of the F3 mutant was  slightly more efﬁcient than of the
wild-type protein. These results indicate that the F3 motif is not
involved in mediating the length-dependent effect of DNA on full-
length PARP-1 sumoylation. Hence, it is likely that other regions
of the protein, possibly the WGR  domain [20], contribute to the
recognition of long intact DNA.
3.6. DNA binding enhances PARP-1’s afﬁnity for Ubc9
Our observations raised the question as to how DNA enhances
PARP-1 sumoylation. Direct binding of the E2, Ubc9, to DNA could
be responsible for the stimulatory effect. Alternatively, binding to
DNA could trigger a conformational change within PARP-1 lead-
ing to an enhanced afﬁnity for the Ubc9-SUMO thioester, either
through the exposure of a SUMO interaction motif (SIM) or by
means of direct interactions with Ubc9. In order to distinguish
between these scenarios, we  performed a series of pulldown
assays under conditions similar to those that had been found to
efﬁciently stimulate PARP-1 sumoylation. When coupled to strep-
tavidin agarose via a biotin linkage, a 15 bp duplex DNA efﬁciently
retained F1 + F2, but not GSTUbc9 (Fig. 6A and B), thus ruling out
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Fig. 5. DNA length affects the efﬁciency of PARP-1 sumoylation. (A) The F2 domain is required for the effects of intact and SSB-containing DNA on PARP-1 sumoylation. WT
and  R122/138I mutant PARP-1 (3 pmol) were sumoylated in the presence of nicked (6 pmol) or intact (1.5, 3 or 6 pmol) dumbbell. (B) The nicked dumbbell abolishes the
stimulatory effect of the intact dumbbell on PARP-1 sumoylation by competition. The assay was  carried out as in panel A with 3 pmol intact dumbbell and increasing amounts
of  nicked dumbbell (0.38, 0.75, 1.5, 3 and 6 pmol). (C) A minimal length of dsDNA is required for stimulation of PARP-1 sumoylation. Reactions were set up as in panel A, but
in  the presence of 3 pmol of the indicated oligonucleotides. Plasmid DNA (240 ng) served as a control. (D) dsRNA does not stimulate PARP-1 sumoylation. Reactions contained
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Fig. 6. DNA binding by F1 + F2 promotes interaction with Ubc9. (A) GSTUbc9 does not bind to a 15 bp duplex DNA immobilised on streptavidin agarose via a biotin linkage.
Unlabelled DNA is used as a negative control. (B) Under the same conditions, PARP-1 F1 + F2 binds to the 15 bp duplex. (C) PARP-1 F1 + F2 is not signiﬁcantly retained by
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6UMO-2 agarose in the presence or absence of DNA. Underivatised agarose is used
ARP-1 F1 + F2 binds to GSTUbc9 immobilised on glutathione Sepharose in the prese
o immobilised GSTUbc9 in the absence of DNA.
 direct interaction between Ubc9 and DNA. Non-covalent inter-
ctions between SUMO and F1 + F2 in the presence or absence
f plasmid DNA were assayed using SUMO-2 coupled to agarose
eads, but no signiﬁcant retention of the PARP-1 fragment was
bserved (Fig. 6C), even though Ubc9 efﬁciently bound to the beads
nder the same conditions (Fig. 6D). Hence, DNA binding does not
ead to the exposure of an obvious SIM. Finally, we used immo-
ilised GSTUbc9 to examine a potential interaction with F1 + F2.
hile no binding was detected in the absence of DNA, addition
f DNA promoted the retention of F1 + F2 on the beads (Fig. 6E).
n contrast, SUMO bound to GSTUbc9 even in the absence of DNA
Fig. 6F). Given that Ubc9 itself does not bind to DNA, these results
uggest that DNA indeed causes a conformational change in F1 + F2
hat leads to an enhanced afﬁnity for the E2.
.7. PARP-1 sumoylation is enhanced by chromatin, but not by
NA  damage
In  order to assess whether the enhancement of PARP-1 sumoyla-
ion by DNA was relevant in the context of chromatin, we examined
he ability of a synthetic array of 60 nucleosomes, assembled on an
1 kbp dsDNA, to stimulate the reaction. Fig. 7A shows that the
ucleosome array was almost as effective in promoting PARP-1
umoylation as the corresponding naked dsDNA.
Sumoylation of PARP-1 in vivo was detected by co-transfection
f mammalian cells with FLAG3-PARP-1 and His6-SUMO-1. The two
ajor sumoylation sites, K203 and K486, were conﬁrmed by the
ppearance of two PARP-1-speciﬁc conjugates of ca. 150 kDa, which
ere either abolished or reduced in intensity upon mutation of the
espective lysines to arginine (Fig. 7B). However, the modiﬁcation
attern observed in the K203/486R double mutant indicated that
t least one additional lysine was used in the absence of the two
ajor acceptor sites. Although K512 was identiﬁed as a relevant
ite in vitro (Fig. S4), the remaining signal in the K486/512R double
 pmol PARP-1 and 1 pmol of the indicated oligonucleotides. (E) Sumoylation of an F2 m
ncreasing amounts of the indicated dsDNA oligonucleotide (0.38, 0.75, 1.5, 3 and 6 pmol)
ARP-1 (3 pmol). (G) Time course of PARP-1 sumoylation stimulated by 20 ng (≈30 pmo
 pmol) inhibits the stimulatory effect of short, but not long dsDNA (3 pmol) on the sumoynegative control. (D) GSTUbc9 binds to SUMO-2 agarose in the absence of DNA. (E)
ut not in the absence of DNA. GST is used as a negative control. (F) SUMO-1 binds
mutant  suggested additional redundancy among the sumoylation
sites in vivo. K233 and K249 were identiﬁed as potential sumoy-
lation sites by bioinformatic analysis, but the modiﬁcation pattern
remained unchanged in the respective mutants.
Sumoylation of PARP-1 was previously reported to be induced
by heat shock [33], but the inﬂuence of other environmental stimuli,
particularly the effect of DNA damage, had not been examined. We
therefore determined the extent of endogenous PARP-1 sumoy-
lation in response to a series of stress conditions, including heat,
osmotic, ethanol and oxidative stress, by means of Ni-NTA pull-
down of His6-SUMO-3 conjugates from total HeLa cell extracts.
While in our hands no signiﬁcant reaction to heat shock was
observed, the extent of PARP-1 sumoylation followed the overall
pattern of total SUMO-3 conjugates in that it was enhanced mainly
by oxidative and to some extent by osmotic shock (Fig. 7C). As the
strong response to oxidative stress could equally be due to pro-
tein or DNA damage, we applied a series of other DNA-damaging
agents known to cause SSBs and/or DSBs. Importantly, none of
them induced PARP-1 sumoylation above the basal level observed
in untreated cells (Fig. 7D).
In order to determine whether in vivo sumoylation of PARP-
1 is at all affected by DNA, we isolated His6-SUMO-3 conjugates
from the soluble and the chromatin-associated fractions of HeLa
cell extracts. Sumoylated PARP-1 was exclusively found in the chro-
matin, whether or not the cells had suffered DNA damage (Fig. 7E).
Consistent with our in vitro data, this strongly suggested that in vivo
the reaction also occurs in association with DNA, but is independent
of DNA lesions.
3.8.  PARP-1 activation and sumoylation are controlled
independently in vivo
The question of a possible cross-talk between PARP-1 sumoy-
lation and the enzyme’s catalytic activation by DNA damage was
utant of PARP-1 (3 pmol) is stimulated only by long oligonucleotides (3 pmol). (F)
 were added to in vitro sumoylation reactions containing WT or R122/138I mutant
l bp) of supercoiled plasmid DNA. (H) The nicked dumbbell (0.38, 0.75, 1.5, 3 and
lation of PARP-1 (3 pmol). All blots were developed with an anti-PARP-1 antibody.
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Fig. 7. PARP-1 sumoylation is stimulated by chromatin, but not by DNA damage. (A) In vitro sumoylation of PARP-1 (3 pmol) in the presence of 240 ng of plasmid DNA or an
11  kbp duplex, supplied either as unoccupied dsDNA or as an array of 60 nucleosomes. (B) PARP-1 is sumoylated at multiple sites in HEK293 cells transfected with FLAG3-
PARP-1  and His6-SUMO-1. Sumoylated species were isolated by Ni-NTA afﬁnity chromatography, and PARP-1-speciﬁc conjugates were detected by anti-FLAG western blot.
(C)  Sumoylation of endogenous PARP-1 in HeLa cells is stimulated by oxidative stress. HeLa cells producing His6-SUMO-3 were subjected to the indicated stress conditions,
and SUMO-3 conjugates were isolated by Ni-NTA afﬁnity chromatography. (D) Sumoylation of PARP-1 in HeLa cells is not induced by DNA damage. SUMO-3 conjugates were
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ddressed by means of a PARP-1 inhibitor, PJ34, whose action
esults in the trapping of the enzyme at strand breaks and
reventing its release. Treatment with the inhibitor prevented
uto-poly(ADP-ribosylation) of PARP-1, but did not abolish its
umoylation under conditions of either oxidative stress or DNA
amage (Fig. 7F). In fact, sumoylation appeared to be slightly
nhanced, consistent with the prolonged residence of PARP-1 on
NA upon inhibition.
The  notion that PARP-1’s catalytic activation appears to be
ontrolled separately from its sumoylation raised the possibility
hat there might be two distinct populations of PARP-1, involved
n damage-induced poly(ADP-ribosylation) and possibly SUMO-
ediated transcriptional regulation, respectively. In order to ﬁnd
vidence for or against this scenario, we asked whether the
wo modiﬁcations ever coincide on PARP-1 in vivo. Isolation of
is6-SUMO-3 conjugates from H2O2-treated cells revealed a faint
and of poly(ADP-ribose)-reactive material at a size consistent
ith doubly modiﬁed PARP-1, which disappeared upon treatment
ith PARP-1 inhibitor (Fig. 7G). Thus, poly(ADP-ribosylation) and
umoylation of PARP-1 are not mutually exclusive, but the degree
f overlap appears to be minor. Taken together, these ﬁndings sug-
est that the damage-induced catalytic activation of PARP1 and its
umoylation are mediated by independent regulatory circuits.
.  Discussion
.1. PARP-1 sumoylation is guided by DNA structure
In this study, we have examined the impact of DNA on the
umoylation of PARP-1 and have delineated which parts of the
rotein contribute to sensing the nature of the DNA. Our ﬁndings
uggest that PARP-1 sumoylation is stimulated by regular B-form
NA without any unusual features. The binding of PARP-1 to such
NA has been controversial [16,42–44], but our observation that
2 alone was capable of differentiating between nicked and intact
NA argues in favour of a model where this domain can interact
ith undamaged DNA. In this mode, the protein was efﬁciently
umoylated. In contrast, binding to a DNA carrying a SSB did not
nhance sumoylation, and due to the much higher afﬁnity of F2 for
amaged versus undamaged DNA, small amounts of nicks effec-
ively inhibited sumoylation at K203 even in the presence of a large
xcess of intact DNA. Binding to intact DNA by F2 is consistent with
he structure of this domain, revealing robust contacts between the
rotein and the uninterrupted sugar-phosphate backbone of a DNA
igand [17]. In the context of the full-length protein, we  observed
hat the critical inﬂuence of F2 was overcome by long stretches of
sDNA. Thus, additional domains must also contribute to the recog-
ition of intact DNA. Having excluded the F1 and F3 domains, we
onsider the WGR  domain the most likely candidate, as this was
ecently shown to make extensive contacts to the sugar-phosphate
ackbone in the recognition of a DSB [20].
The impact of DNA structure on PARP-1 sumoylation suggests
 mechanism of signalling across the protein, where recognition of
 small duplex by F2 promotes a conformational change in PARP-1
hat causes an enhanced afﬁnity for Ubc9, which may  be sufﬁ-
ient to cause sumoylation at lysines situated outside PARP-1’s
NA-binding domain, such as K486. This process is reminiscent
f the activation of PARP-1’s C-terminal catalytic domain by bind-
ng of its N-terminal region to damaged DNA. The crystal structure
solated and detected as above after treating the cells as indicated. (E) Sumoylated PARP-
oluble  and chromatin-associated fractions, and PARP-1 SUMO conjugates were detected
oluble  and chromatin-associated proteins, respectively. (F) PARP-1 inhibition does not in
reatments with PARP-1 inhibitor PJ34 as described for panel C. (G) PARP-1 can be simu
solated after the indicated treatments as above, and doubly modiﬁed species were detec12 (2013) 761– 773 771
of  selected PARP-1 domains in complex with a DSB [20] has
given insight into how this activation is accomplished: cooperation
between the F1, F3 and WGR  domains in DNA binding causes them
to collapse onto the DNA, leading to a signiﬁcant perturbance of the
catalytic domain and thereby its activation. A similar mechanism
could in principle apply to the stimulation of PARP-1 sumoylation.
However, F2 is dispensable for catalytic activation of the enzyme
in response to DSBs, while sumoylation was  found to be controlled
mainly by F2, but was unaffected by F1 and F3. Hence, the way in
which DNA structure inﬂuences PARP-1 conformation and acces-
sibility likely differs between the two  phenomena. Structures of
PARP-1 bound to SSBs and most importantly to intact DNA may
provide further insight.
4.2.  Independent regulation of PARP-1 sumoylation and catalytic
activation
PARP-1 contributes to a variety of DNA-associated processes,
ranging from DNA repair to a modulation of chromatin struc-
ture [12,14,15]. Strand breaks activate PARP-1’s enzymatic activity,
which leads to the modiﬁcation of chromatin-associated proteins
and PARP-1 itself [12]. Conversely, we now show that binding to
intact DNA strongly stimulates PARP-1 sumoylation, which has in
turn been implicated in transcriptional regulation [32,33]. Con-
sistent with these in vitro data, sumoylated PARP-1 is found in
association with chromatin, but the modiﬁcation is not enhanced
by DNA damage. Based on these observations, we  propose that the
way in which PARP-1 recognises DNA may  inﬂuence whether it is
modiﬁed by SUMO or not, thus providing a means to delineate two
distinct functionalities of the enzyme.
In the context of the DNA damage response, synthesis of
poly(ADP-ribose) is believed to cause a general decompaction of
chromatin to provide access to the site of damage, and it facilitates
the recruitment of speciﬁc repair factors [26–30]. In this situation,
PARP-1’s catalytic activity is stimulated through its binding to dam-
aged DNA, but sumoylation would not be required. Although we
observed that DNA strand breaks do not directly inhibit sumoyla-
tion of the full-length protein when a sufﬁcient stretch of dsDNA is
available, PARP-1’s rapid auto-poly(ADP-ribosylation) upon bind-
ing to damaged DNA would likely prevent extensive sumoylation
in vivo by causing the release of the enzyme from DNA, thus remov-
ing the stimulus [15].
Transcriptional regulation often appears to involve a modula-
tion of chromatin structure via poly(ADP-ribose) synthesis as well
[25]. Yet, the enzyme can also act more directly as a co-regulator,
which would involve an association with intact DNA, but not nec-
essarily its catalytic activity [31]. Particularly this latter aspect of
PARP-1 function might be subject to modulation by SUMO,  as sug-
gested by the ﬁnding that the modiﬁer interferes with the enzyme’s
function as a co-activator of HIF1- [32]. In this or a similar con-
text, stimulation of PARP-1 sumoylation by association with intact
DNA would help to direct the modiﬁcation to chromatin-associated
molecules. Hence, the inﬂuence of DNA structure on sumoylation
efﬁciency could serve as an elegant mechanism to limit PARP-1
sumoylation to the appropriate locations. As we have shown in
Fig. 6G, automodiﬁcation and sumoylation are not mutually exclu-
sive; hence, there may  be situations in which both modiﬁcations
work hand in hand. For example, a recent study reported a rapid,
heat shock-induced activation of PARP-1 at the HSP70 promoter
[45], where PARP-1 sumoylation was also observed to impinge
1 is associated with chromatin in vivo. Total HeLa cell lysates were fractionated in
 in the fractions by Ni-NTA pulldown. GAPDH and histone H3 served as controls for
ﬂuence PARP-1 sumoylation. SUMO-3 conjugates were isolated after the indicated
ltaneously auto-poly(ADP-ribosylated) and sumoylated. SUMO-3 conjugates were
ted by anti-poly(ADP-ribose) (PAR) western blot.
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n transcription [33]. However, a detailed analysis of the kinetics
f PARP-1 modiﬁcations at speciﬁc promoters will be required to
etermine the relationship between automodiﬁcation and sumoy-
ation in transcriptional control.
.3. Structure of the PARP-1 SUMO conjugate and its functional
mplications
The  absence of major chemical shift differences outside the
egion surrounding the SUMO acceptor site, K203, between sumoy-
ated and unmodiﬁed F1 + F2 indicates that the modiﬁcation does
ot induce major changes in the conformation of PARP-1’s DNA-
inding domain. In this respect, the structure of sumoylated F1 + F2
esembles those of other covalent SUMO conjugates, which mostly
dhere to a “beads-on-a-string” model where SUMO is ﬂexibly teth-
red to its substrate without extensive non-covalent contacts or
hanges to the conformations of the target protein or SUMO itself
46–50]. Consistently, sumoylation changes neither the afﬁnity of
1 + F2 for DNA nor the catalytic activity of the full-length pro-
ein. These observations suggest a uni-directional inﬂuence of DNA
n PARP-1 sumoylation. Rather than directly modifying PARP-1’s
roperties, SUMO is therefore likely to function by creating an addi-
ional or blocking an existing interaction surface for downstream
ffector proteins. The two  effects are not mutually exclusive, and
here is evidence that both might apply in the case of PARP-1: in
he context of hypoxia-responsive genes, SUMO was shown to pre-
ent PARP-1 acetylation through interference with p300 binding,
hereby reducing transcriptional activity [32]. In response to heat
hock, SUMO was instead proposed to promote the recognition of
ARP-1 by the SUMO-targeted ubiquitin ligase RNF4 and contribute
o the activation of HSP70.1 transcription by facilitating proteaso-
al turnover of PARP-1 [33]. Our own data support this scenario:
e found that mutating the main sumoylation sites of PARP-1
n vivo stabilised the enzyme to a similar extent as treatment
ith the proteasome inhibitor MG132 (Fig. S8). Whether there is
 common principle as to how PARP-1 sumoylation impinges on
ranscription has yet to be established. A systematic analysis of the
ffect of SUMO on PARP-1-responsive genes is expected to provide
he necessary mechanistic insight.
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